Dermisonics Profitability Analysis

Based on Dermisonics' profitability indicators, Dermisonics may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Dermisonics' ability to earn profits and add value for shareholders.
For Dermisonics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Dermisonics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Dermisonics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Dermisonics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Dermisonics over time as well as its relative position and ranking within its peers.
Check out Investing Opportunities.
For more detail on how to invest in Dermisonics Stock please use our How to Invest in Dermisonics guide.
Is Medical Devices space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dermisonics. If investors know Dermisonics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dermisonics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Dermisonics is measured differently than its book value, which is the value of Dermisonics that is recorded on the company's balance sheet. Investors also form their own opinion of Dermisonics' value that differs from its market value or its book value, called intrinsic value, which is Dermisonics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dermisonics' market value can be influenced by many factors that don't directly affect Dermisonics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dermisonics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dermisonics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dermisonics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Dermisonics Return On Asset vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Dermisonics's current stock value. Our valuation model uses many indicators to compare Dermisonics value to that of its competitors to determine the firm's financial worth.
Dermisonics is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dermisonics' earnings, one of the primary drivers of an investment's value.

Dermisonics Return On Asset vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Dermisonics

Return On Equity

 = 

Net Income

Total Equity

 = 
-3.92
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Dermisonics

Return On Asset

 = 

Net Income

Total Assets

 = 
-0.12
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

Dermisonics Return On Asset Comparison

Dermisonics is currently under evaluation in return on asset category among its peers.

Dermisonics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Dermisonics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Dermisonics will eventually generate negative long term returns. The profitability progress is the general direction of Dermisonics' change in net profit over the period of time. It can combine multiple indicators of Dermisonics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Dermisonics, Inc. manufactures ultrasonic transdermal drug-delivery technologies and equipment. Dermisonics, Inc. was founded in 2000 and is based in Irvine, California. Dermisonics is traded on OTC Exchange in the United States.

Dermisonics Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Dermisonics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Dermisonics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Dermisonics' important profitability drivers and their relationship over time.

Use Dermisonics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dermisonics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermisonics will appreciate offsetting losses from the drop in the long position's value.

Dermisonics Pair Trading

Dermisonics Pair Trading Analysis

The ability to find closely correlated positions to Dermisonics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dermisonics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dermisonics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dermisonics to buy it.
The correlation of Dermisonics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dermisonics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dermisonics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dermisonics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Dermisonics position

In addition to having Dermisonics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Video Games Thematic Idea Now

Video Games
Video Games Theme
Companies that are involved in the building and marketing of video games or gaming software. The Video Games theme has 22 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Video Games Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Dermisonics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dermisonics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dermisonics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dermisonics Stock:
Check out Investing Opportunities.
For more detail on how to invest in Dermisonics Stock please use our How to Invest in Dermisonics guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
To fully project Dermisonics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Dermisonics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Dermisonics' income statement, its balance sheet, and the statement of cash flows.
Potential Dermisonics investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Dermisonics investors may work on each financial statement separately, they are all related. The changes in Dermisonics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Dermisonics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.